Showing 31 - 40 of 67
Objective To contribute to the debate whether extending public coverage of influenza vaccination to healthy workers is cost-effective, particularly in the perspective of EU countries.Methods First, we reviewed the recent international literature on the extension of vaccination to subjects aged...
Persistent link: https://www.econbiz.de/10009249941
Persistent link: https://www.econbiz.de/10009404208
Persistent link: https://www.econbiz.de/10009404255
Objective We examined Continuing Medical Education (CME) systems in a sample of six EU countries: Austria, Belgium, France, Italy, Norway, and the UK. The aim of this comparative study was to assess the main country-specific institutional settings applied by governments.Methods A common scheme...
Persistent link: https://www.econbiz.de/10008620243
Persistent link: https://www.econbiz.de/10009149816
Persistent link: https://www.econbiz.de/10010698251
Persistent link: https://www.econbiz.de/10010634521
The number of biological agents (BAs) registered with an indication related to cancer treatment is flourishing and the cost of these treatments is rising dramatically, making the situation potentially unsustainable for healthcare systems. Here we focus on the examples of bevacizumab (BV) and...
Persistent link: https://www.econbiz.de/10010603313
Persistent link: https://www.econbiz.de/10000979360
Persistent link: https://www.econbiz.de/10001206876